Market Research Logo

Global Asthma Therapeutics Market 2016-2020

About Asthma Therapeutics

Increasing allergic rhinitis is a major factor for allergic asthma leading to increase in research for the development of allergic immunotherapies for the treatment of asthma. The global asthma therapeutics market will observe a moderate growth during the forecast period because of loss of patent exclusivity of the major drugs, allowing the entry of generics into the market. This will lead to the erosion of the market share of the major asthma drugs. However, the presence of late-stage pipeline molecules will drive the market. An increase in the prevalence of asthma and the use of combination drugs will drive the growth of the market during the forecast period.

Technavio’s analysts forecast the global asthma therapeutics market to grow at a CAGR of 4.31% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global asthma therapeutics market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the sales of brand-name, generic, and off-label drugs used for the prevention and treatment of asthma. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from patent expiries of marketed drugs during the forecast period.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Asthma Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AstraZeneca
  • Boehringer Ingelheim
  • F. Hoffmann-La Roche
  • GSK
  • Merck
Other prominent vendors
  • ALK-Abello
  • Amgen
  • Array BioPharma
  • Asmacure
  • Astellas Pharma
  • Atopix Therapeutics
  • Axikin Pharmaceuticals
  • Chiesi Farmaceutici
  • Dynavax Technologies Corp.
  • Horizon Pharma
  • Hovione Scientia
  • Invion
  • Ivax
  • Kissei Pharmaceutical
  • Kyowa Hakko Kirin
  • MediciNova
  • Mitsubishi Tanabe Pharma Corporation
  • Mundipharma
  • Nycomed
  • Oxagen Limited
  • Palobiofarma
  • Pearl Therapeutics
  • Pharmaking
  • Pharmaxis
  • Pulmagen Therapeutics
  • Regeneron Pharmaceuticals
  • Revalesio
  • RSPR Pharma AB
  • SAMA Pharmaceuticals
  • Sanofi
  • Skyepharma
  • SolAeroMed
  • Stallergenes
  • Sterna Biologicals
  • Synairgen
  • Theron Pharmaceuticals
  • UCB Pharma
  • Vectura
  • Verona Pharma
  • Whanin Pharmaceutical Company
Market driver
  • Huge market potential for mAbs
  • For a full, detailed list, view our report
Market challenge
  • Increased preference for CAM
  • For a full, detailed list, view our report
Market trend
  • Innovative technologies for drug delivery
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Asthma Therapeutics Market 2016-2020

Technavio recognizes the following companies as the key players in the global asthma therapeutics market: AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche, GSK, Merck,

Other Prominent Vendors in the market are: ALK-Abello, Amgen, Array BioPharma, Asmacure, Astellas Pharma, Axikin Pharmaceuticals, Chiesi Farmaceutici, Dynavax Technologies, Horizon Pharma, Hovione Scientia, Invion, Ivax, Kissei Pharmaceutical, Kyowa Hakko Kirin, MediciNova, Mitsubishi Tanabe Pharma, Mundipharma, Nycomed, Oxagen Limited, Palobiofarma, Pearl Therapeutics, Pharmaking, Pharmaxis, Pulmagen Therapeutics, Regeneron Pharmaceuticals, Revalesio, RSPR Pharma AB, SAMA Pharmaceuticals, Sanofi, Skyepharma, SolAeroMed, Stallergenes, Sterna Biologicals, Synairgen, Theron Pharmaceuticals, UCB Pharma, Vectura, Verona Pharma, and Whanin Pharmaceutical.

Commenting on the report, an analyst from Technavio’s team said: “One of the key trends for market growth will be innovative technologies for drug delivery. The industry's shift toward electronic systems technology like smart technology and EHR brings the level of perspective and accessibility across healthcare specialties. This reduces cost when administering expensive medications. Other recent advances include integration of add-on devices such as spacers, breath-actuated devices, and valved holding chambers in inhalers. They help in reducing oropharyngeal deposition of inhaled corticosteroids and minimizes side effects.”

According to the report, one of the key drivers for market growth will be huge market potential for mAbs. mAbs will have a high uptake for the treatment of asthma, owing to the development of target specific drugs. mAbs blocking IgE are specifically approved for the treatment of allergic asthma. Asthmatic patients with phenotypes of severe refractory asthma will benefit from these mAbs. mAbs against immunoglobulin or specific cytokines, which are known to be important in the initiation or persistence of asthmatic inflammation are being developed. Xolair was the first mAb approved for the treatment of allergic asthma.

Further, the report states that once of the challenges for the market will be increased preference for CAM. Individuals with allergic rhinitis and asthma tend to adopt alternative methods of treatment instead of pharmacologic treatment. According to a 2016 report, in the US above 20% of the population suffer from allergic diseases, including allergic asthma, allergic rhinitis, and atopic dermatitis, and more than 42% of the people use CAM for these conditions. The use of CAM for allergic conditions is higher in some European countries because of its better efficacy, favorable safety, and low cost of therapies.



Companies Mentioned

AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche, GSK, Merck, ALK-Abello, Amgen, Array BioPharma, Asmacure, Astellas Pharma, Axikin Pharmaceuticals, Chiesi Farmaceutici, Dynavax Technologies, Horizon Pharma, Hovione Scientia, Invion, Ivax, Kissei Pharmaceutical, Kyowa Hakko Kirin, MediciNova, Mitsubishi Tanabe Pharma, Mundipharma, Nycomed, Oxagen Limited, Palobiofarma, Pearl Therapeutics, Pharmaking, Pharmaxis, Pulmagen Therapeutics, Regeneron Pharmaceuticals, Revalesio, RSPR Pharma AB, SAMA Pharmaceuticals, Sanofi, Skyepharma, SolAeroMed, Stallergenes, Sterna Biologicals, Synairgen, Theron Pharmaceuticals, UCB Pharma, Vectura, Verona Pharma, Whanin Pharmaceutical.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
    • Breakthrough in asthma research
      • Table Breakthrough in asthma research
    • Asthma: An overview
      • Table Major diagnostic procedures for asthma
  • Pipeline portfolio
    • Table Percentage share of pipeline molecules based on stage of development
    • Table Pipeline portfolio: Global asthma therapeutics market
  • Market landscape
    • Market overview
      • Table Global asthma drugs market: Market overview 2015
    • Market size and forecast
      • Table Global asthma therapeutics market 2015-2020 ($ billions)
      • Table Global asthma drugs market snapshot: Developed and emerging markets 2015
      • Table Global asthma therapeutics market: Key parameters driving the market growth 2015
    • Five forces analysis
      • Table Five forces analysis
  • Key buying criteria for asthma drugs
    • Table Key buying criteria for asthma drugs
    • Table Global asthma therapeutics market: Key parameters importance
    • Table Impact of key customer segments on market
  • Market segmentation by type of treatment
    • Table Segmentation of asthma drugs based on type of treatment
    • Preventive medications
    • Quick-relief medications
    • Others
  • Market segmentation by drug class
    • Table Segmentation of asthma drugs based on drug class
    • Table Percentage share of global asthma therapeutics by drug class based on revenue 2015
    • Table Global asthma therapeutics market: Drug class segmentation growth cycle analysis 2015
    • Combination therapies
      • Table Combination therapies market in global asthma therapeutics market 2015-2020 ($ billions)
    • Bronchodilators
      • Table Bronchodilators market in global asthma therapeutics market 2015-2020 ($ billions)
    • Immunosuppressants
      • Table Percentage share of allergy immunotherapies and steroids in global immunosuppressants market 2015
      • Table Immunosuppressants market in global asthma therapeutics market 2015-2020 ($ billions)
    • Leukotriene antagonists
      • Table Leukotriene antagonists market in global asthma therapeutics market 2015-2020 ($ billions)
    • Mast cell stabilizers
      • Table Mast cell stabilizers market in global asthma therapeutics market 2015-2020 ($ billions)
  • Segmentation by route of administration
    • Table Segmentation of global asthma therapeutics market by route of administration
    • Inhalation
    • Parenteral
    • Oral
  • Drug delivery devices market for asthma drugs
    • Market overview
      • Table Global asthma drug delivery devices market 2015-2020 ($ millions)
    • Market segmentation by product type
      • Table Global asthma drug delivery devices market segmentation by product type
      • Table Percentage share of global asthma drug delivery devices by type 2015
      • Table Percentage share of inhalers in global asthma drug delivery devices market 2015
      • Table Inhalers market in global asthma drug-delivery devices market 2015-2020 ($ millions)
      • Table Percentage share of nebulizers in global asthma drug delivery devices market 2015
      • Table Nebulizers market in global asthma drug-delivery devices market 2015-2020 ($ millions)
  • Geographical segmentation
    • Global asthma therapeutics market by geography 2015-2020
      • Table Global asthma therapeutics market by geography 2015-2020
      • Table Percentage share of global asthma therapeutics market by geography 2015 and 2020
      • Table Global asthma therapeutics market segmentation by geography 2015-2020 ($ billions)
      • Table Global share of asthma therapeutics market by geography 2015
      • Table Global asthma therapeutics market: Country analysis based on revenue and growth rate
    • Asthma therapeutics market in Americas
      • Table Impact of ACA act on asthma therapeutics market
      • Table Asthma therapeutics market in Americas 2015-2020 ($ billions)
      • Table Asthma therapeutics market: PEST analysis
    • Asthma therapeutics market in EMEA
      • Table Prevalence of asthma in major countries of EMEA
      • Table Asthma therapeutics market in EMEA 2015-2020 ($ billions)
      • Table Asthma therapeutics market in EMEA: PEST analysis
    • Asthma therapeutics market in APAC
      • Table Asthma therapeutics market in APAC 2015-2020 ($ billions)
      • Table Asthma therapeutics market: PEST analysis
  • Market drivers
    • Huge market potential for mAbs
      • Table mAbs approved for treatment of asthma
      • Table mAbs under development for treatment of asthma
    • New product approvals minimizing the impact of generic erosion
    • Increasing rate of allergies due to environmental pollution
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Increased preference for CAM
      • Table Use of CAM therapies among individuals in US
    • Poor patient adherence toward controller medications
    • Presence of different phenotypes of asthma leading to prescription errors
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Innovative technologies for drug delivery
    • Growing adoption of immunotherapies
    • Shift toward immune/inflammatory system targets from glucocorticoid and adrenergic receptors
    • Increase in online marketing services
    • Growing use of home healthcare devices
  • Vendor landscape
    • Competitive scenario
      • Table Market share of major vendors based on asthma therapeutics revenue 2015
      • Table Competitive scenario of global asthma therapeutics market vendors 2015-2020
      • Table Geographical presence of key vendors
    • Key news
  • Key vendor analysis
    • AstraZeneca
      • Table AstraZeneca: YoY revenue and growth rate of Symbicort 2013-2015 ($ billions)
      • Table AstraZeneca: Geographical segmentation of Symbicort 2015
      • Table AstraZeneca: YoY revenue and growth rate of Pulmicort 2013-2015 ($ millions)
      • Table AstraZeneca: Geographic segmentation of Pulmicort 2015
      • Table AstraZeneca: Metrics analysis
    • Boehringer Ingelheim
      • Table Boehringer Ingelheim: YoY revenue and growth rate of Spiriva 2013-2015 ($ billions)
      • Table Boehringer Ingelheim: Metrics analysis
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: YoY revenue and growth rate of Xolair 2012-2014 ($ millions)
      • Table F. Hoffmann-La Roche: Metrics analysis
    • GSK
      • Table GSK: YoY revenue and growth rate of Seretide/Advair 2013-2015 ($ billions)
      • Table Geographical segmentation of Seretide/Advair 2015
      • Table GSK: YoY revenue and growth rate of Flixotide/Flovent 2013-2015 ($ billions)
      • Table GSK: Geographical segmentation of Flixotide/Flovent 2015
      • Table GSK: YoY revenue and growth rate of Ventolin 2013-2015 ($ billions)
      • Table GSK: Geographical segmentation of Ventolin 2015
      • Table GSK: YoY growth and revenue of Relvar/Breo Ellipta 2014-2015 ($ millions)
      • Table GSK: Geographical segmentation of Relvar/Breo Ellipta 2015
      • Table GSK: Metrics analysis
    • Merck
      • Table Merck: YoY growth and revenue of Singulair 2013-2015 ($ millions)
      • Table Merck: YoY growth and revenue of Dulera 2013-2015 ($ millions)
      • Table Merck: Metrics analysis
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report